Scientists have identified a little-known receptor, GPR133, as a powerful regulator of bone strength. By activating it with a newly discovered compound called AP503, they were able to boost bone ...

This strategic partnership with WuXi XDC represents a major milestone for Akari and a powerful validation of our novel PH1 ...

Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel RNA splicing ...

There is growing demand for treatments that can safely prevent and reverse bone loss over time. Osteoporosis, a condition that weakens bones and makes ...

Mechanosensitive recruitment of DLC1 to focal adhesions creates a positive feedback loop that locally amplifies Rho activation in response to tension.

Invariant natural killer T cells have emerged as a potentially versatile allogeneic platform for blood cancer immunotherapy, ...

All processes such as wound healing, hair growth, and the replacement of old cells with new ones depend on cell division.

Leukemia is adept at dodging the immune system, making it resistant to many of the newest generation of cancer ...

University of Tennessee Knoxville professor and Goodrich Chair of Excellence in Civil Engineering Frank Loeffler and his ...

Scientists at Oregon Health & Science University have uncovered a previously unknown system of internal “trade winds” that ...

Metastases are a key problem in many types of cancer. As descendants of the primary tumor, they can grow in other organs ...

Peptides like insulin and the now-ubiquitous GLP-1 drugs have become some of the most influential molecules in modern ...